Long COVID Trial, Recruiting (NCT06248151)

Long COVID Trial, Recruiting NCT06248151 Sponsor: University of Nove de Julho Condition: Long COVID

Printed from Voxsanity (voxsanity.com.au) — NCT06248151 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Long Covid

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the Post-Covid Syndrome group:

You have had a confirmed positive PCR test for Covid-19
You are still experiencing ongoing symptoms that are linked to Long Covid (as defined by the World Health Organization), with no other medical explanation for those symptoms
You are physically and mentally able to take part in exercise activities
You are considered low risk for heart and cardiovascular problems, based on guidelines from the American College of Sports Medicine (confirm with trial site)

For the Healthy Comparison group:

You do not have any ongoing symptoms that would be considered Long Covid (as defined by the World Health Organization)
You are physically and mentally able to take part in exercise activities
You are considered low risk for heart and cardiovascular problems, based on guidelines from the American College of Sports Medicine (confirm with trial site)

Who may not be able to join:

People whose ongoing symptoms after Covid-19 have another known medical explanation
People who do not have the physical or mental ability to perform the required exercises
People who are considered moderate or high risk for heart or cardiovascular problems (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raphael Dias, PhD, University of Nove de Julho

Phone: +5519999406878

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06248151

Sponsor: University of Nove de Julho

Phase: Not Applicable

Status: Recruiting

Condition: Long COVID

Trial contact: +5519999406878

More information: https://clinicaltrials.gov/study/NCT06248151

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For the Post-Covid Syndrome group:

You have had a confirmed positive PCR test for Covid-19
You are still experiencing ongoing symptoms that are linked to Long Covid (as defined by the World Health Organization), with no other medical explanation for those symptoms
You are physically and mentally able to take part in exercise activities
You are considered low risk for heart and cardiovascular problems, based on guidelines from the American College of Sports Medicine (confirm with trial site)

For the Healthy Comparison group:

You do not have any ongoing symptoms that would be considered Long Covid (as defined by the World Health Organization)
You are physically and mentally able to take part in exercise activities
You are considered low risk for heart and cardiovascular problems, based on guidelines from the American College of Sports Medicine (confirm with trial site)

Who may not be able to join:

People whose ongoing symptoms after Covid-19 have another known medical explanation
People who do not have the physical or mental ability to perform the required exercises
People who are considered moderate or high risk for heart or cardiovascular problems (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Nove de Julho

Registry

ClinicalTrials.gov

Start date

15 February 2024

Est. completion

30 December 2024

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Change in Blood pressure; Change in Heart rate variability; Change in flow mediated dilation; Change in peak exhalation flow; Change in oxygen saturation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov